ATH-399A

· HanAll BioPharma Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ATH-399A, covering 2025-12-19 to 2025-12-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study Assessing the Safety of Oral ATH-399A in Healthy Adult Participants [Phase 1]